Catalyst Wire Dossier Catalyst Wire Dossier

AG013

· ActoGeniX N.V.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AG013, covering 2014-01-07 to 2020-11-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day [Phase 2]

See pricing